BIOCON LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.4 INR | +5.06% |
|
+17.10% | +22.73% |
| 18/04 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
| 18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- BIOCON Stock
- Revisions Biocon Limited
